Literature DB >> 15027891

Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to fasting glucose in Chinese colorectal cancer patients.

L Shao1, Q Huang, M Luo, M Lai.   

Abstract

IGF-binding protein-related protein-1 (IGFBP-rP1) is a member of the IGF axis. In our previous work, we separated cDNA fragments of IGFBP-rP1 from colonic adenocarcinoma and normal mucosa cDNA subtraction libraries. In this study, we compared the expression of IGFBP-rP1 by semi-quantitative RT-PCR and immunohistochemistry among colorectal cancer, adenoma, normal tissue adjacent to cancer site, and normal tissue. Associations between IGFBP-rP1 and plasma glucose were further explored. We found that the mRNA level of IGFBP-rP1 was highest in cancer, moderate in adenoma and tissue adjacent to the cancer site and lowest in normal tissue (P<0.05). A significant difference was found in the immunoreactivity of IGFBP-rP1 between paired normal and cancer tissue (P<0.05). Tumor samples with upregulated expression of IGFBP-rP1 in invading tumor cells showed an increased frequency of metastasis to the lymph node, an increased depth of infiltration and stronger staining of IGFBP-rP1 compared with other samples (P<0.05). The fasting glucose level was significantly correlated with the staining of IGFBP-rP1 in cancer tissue (Spearman's rho=0.4, P<0.000). Thus, we concluded overexpression of IGFBP-rP1 might play an important role in the initiation and promotion of colorectal cancer. IGFBP-rP1 expression may also be associated with fasting glucose level and the presence of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15027891     DOI: 10.1677/erc.0.0110141

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  14 in total

1.  IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.

Authors:  Wen-jing Ruan; Jie Lin; En-ping Xu; Fang-ying Xu; Yu Ma; Hong Deng; Qiong Huang; Bing-jian Lv; Hu Hu; Jing Cui; Mei-juan Di; Jian-kang Dong; Mao-de Lai
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

Review 2.  The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.

Authors:  Rajaraman Durai; Wenxuan Yang; Sharmila Gupta; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2005-01-14       Impact factor: 2.571

3.  Decreased expression of insulin-like growth factor binding protein 7 in human colorectal carcinoma is related to DNA methylation.

Authors:  Fei Ye; Yuan Chen; Thomas Knösel; Karsten Schlüns; Manuela Pacyna-Gengelbach; Nicole Deutschmann; Maode Lai; Iver Petersen
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-28       Impact factor: 4.553

Review 4.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

5.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

6.  Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.

Authors:  Karen Gambaro; Michael C J Quinn; Katia Y Cáceres-Gorriti; Rebecca S Shapiro; Diane Provencher; Kurosh Rahimi; Anne-Marie Mes-Masson; Patricia N Tonin
Journal:  BMC Cancer       Date:  2015-03-17       Impact factor: 4.430

7.  IGFBP-rP1 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer.

Authors:  S Zhu; J Zhang; F Xu; E Xu; W Ruan; Y Ma; Q Huang; M Lai
Journal:  Cell Death Dis       Date:  2015-03-19       Impact factor: 8.469

8.  Interaction between IGFBP7 and insulin: a theoretical and experimental study.

Authors:  Wenjing Ruan; Zhengzhong Kang; Youzhao Li; Tianyang Sun; Lipei Wang; Lijun Liang; Maode Lai; Tao Wu
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

9.  Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines.

Authors:  Narendra Wajapeyee; Varun Kapoor; Meera Mahalingam; Michael R Green
Journal:  Mol Cancer Ther       Date:  2009-10-27       Impact factor: 6.261

Review 10.  Insulin-like growth factor-1 deficiency and metabolic syndrome.

Authors:  G A Aguirre; J Rodríguez De Ita; R G de la Garza; I Castilla-Cortazar
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.